Neuro-protective effect of carvedilol, an adrenergic antagonist against scopolamine-induced cognitive impairment in mice

Journal of Applied Pharmaceutical Science

Volumn 3, Issue 8 SUPPL, 2013, Pages

  Yahaya, Tijani Adeniyi ^a   Adeola, Salawu Oluwakanyinsola ^a   Emma, Uboho Unyime ^a  

^a Toxicology National Institute for Pharmaceutical Research and Development   (Nigeria)

Author keywords

Alzheimer's disease; Carvedilol; Memory; Mice

Indexed keywords

EID: 84886285437     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2013.38.S6     Document Type: Article

References (27)

1. Abreu V, Santos L, Moreno M. Effects of Carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress. J Pharm Exp Therap, 2000; 295: 1022-1030.
2. Becker R, 1991. Therapy of the cognitive deficit in Alzheimer's disease: the cholinergic system, in Cholinergic Basis for Alzheimer Therapy (Becker R and Giacobini E eds), Birkhauser, Boston 1-22.
3. Cummings JL and Kaufer D. Neuropsychiatric aspect of Alzheimer's disease: the cholinergic hypothesis revisited. Neurol,1996; 47: 876-883
4. Durairajan SS, Yuan Q, Xie L, Chan WS, Kum WF, Koo I, Liu C, Song Y, Huang JD, Klein WL, Li M. Salvianolic acid B inhibits Aß fibril formation and disaggregatespreformed fibrils and protects against Aß-induced cytotoxicty. Neurochem Inter, 2008;52:741-750.
5. Ebert U, and Kirch, W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Europ J of Clin Inv, 1998;28: 944-949.
6. Feuerstein GZ, Shusterman NH, RuffoloJr RR. Carvedilol update IV: prevention of oxidative stress, cardiac remodeling and progression of congestive heart failure. Drugs Today, 1997; 33:453-457.
7. Germano C, Kinsella GJ. Working memory and learning in early Alzheimer's disease. Neuropsych Rev, 2005; 15: 1-10.
8. Jann MW. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacother, 2000; 20:1-12.
9. Kang SY, Lee KY, Koo KA, Yoon JS, Lim SW, Kim YC, Sung, SH. ESP-102, a standardized combined extract of Angelica gigas, Saururuschinensis and Schizandrachinensis, significantly improved scopolamine-induced memory impairment in mice. Life Sci, 2005;76: 1691-1705.
10. Kim DSHL, Park SY, Kim JK. Curcuminoids from Curcuma longa L. (Zingiberaceae)that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from ßA(1-42) insult. Neurosci Letters, 2001;303:57-61.
11. Kim DH, Hung TM, Bae KH, Jung JW, Lee S, Yoon BH, Cheong JH, Ko KH, Ryu JH. Gomisin A improves scopolamine-induced memory impairment in mice. Europ J. of Pharm, 2007; 542: 129-135.
12. Kumar U, Dunlop DM, Richardson JS: The acute neurotoxic effect of ß-amyloid on mature cultures of rat hippocampal neurons is attenuated by the anti-oxidant U-78517 F. Int. J. of Neurosci,1994;79:185-190.
13. Kumar A, Dogra S. Neuroprotective effect of Carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat. Pharmac Biochem Behav, 2009; 92:25-31.
14. Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein GZ. Neuroprotective effects of Carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke, 1992;23:1630-1636.
15. Lysko PG, Lysko KA, Webb CL, Feuerstein G, Mason PE, Walter MF, Mason RP. Neuroprotective activities of Carvedilol and a hydroxylated derivative, role of membrane biophysical interactions. BiochemPharm,1998;56: 1645-1656.
16. Maèièkova T, Peèivova J, Nosal R, Holomanova D. Influence of Carvedilol on superoxide generation and enzyme release from stimulated human neutrophils. Biomed Pap Med FacUnivPalacky Olomouc Czech Repub, 2005; 149: 389-392
17. Oken BS, Storzbach DM, Kaye JA. The efficacy ofGinkgobiloba on cognitive function in Alzheimer's disease. Arch. of Neurol,1995;55:1409-14015.
18. Parle M, Dhingra D, Kulkarni SK. Neuromodulators of learning and memory. Asia Pacific J. of Pharm, 2004;16:89-99.
19. Perry G, Cash AD, Smith MA. Alzheimer disease and oxidative stress. J of Biomed andBiotech, 2000; 2:120-123.
20. Rahmat A Khan, Muhammad R Khan and SumairaSahre. Brain antioxidant markers, cognitive performance and acetylcholinesterase activity of rats: efficiency of Sonchusasper. Behav Brain Funct, 2012; 8:21
21. Sarter M, Bodewitz G, Stephens DN. Attenuation of scopolamine induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and carboline. Psychopharm, 1988; 94: 491-495.
22. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC. The novel -blocker, Carvedilol, provides neuroprotection in transient focal stroke. J of Cereb Bld Flow Metab, 2000 ;20: 1197-1204.
23. Skolnick AA. Old Chinese herbal medicine used for fever yields possible newAlzheimer's disease therapy. JA M A, 1997;277:776.
24. Souza G, Christina Anna, Cesar Augusto Bruning, Marlon Regis Leite, Gilson Zeni and Christina Wayne Nogueria. Diphenyldiselenide improves scopolamine-induced memory impairment in mice. Behav Pharm, 2010;21:556-562.
25. TijaniAdeniyiYahaya, SalawuOluwakanyinsolaAdeola, Anuka Joseph Akpojo. Crinum zeylanicum bulb extract improves scopolamineinduced memory impairment in mice Mol&Clin. Pharmac, 2012;3(1): 21-29
26. Yaoita H, Sakabe A, Maehara K, Maruyama Y. Differential effects of carvedilol, metoprolol and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circ, 2000;105: 975-980.
27. Yoshioka T, Iwamoto N, Tsukahara F, Irie K, Urakawa I, Muraki T. Anti-NO action of Carvedilol in cell-free system and in vascular endothelial cells. Brit J of Pharm, 2000;129:1530-1535